Právní předpis byl sestaven k datu 03.07.2024.
Zobrazené znění právního předpisu je účinné od 22.02.2023.
Sdělení Ministerstva zdravotnictví o antigenním složení očkovacích látek pro pravidelná, zvláštní a mimořádná očkování pro rok 2023
41/2023 Sb.
41
XXXXXXX
Xxxxxxxxxxxx xxxxxxxxxxxxx
xx xxx 10. xxxxx 2023
x xxxxxxxxxx složení xxxxxxxxxx xxxxx xxx pravidelná, xxxxxxxx x xxxxxxxxx xxxxxxxx xxx xxx 2023
&xxxx;
Xxxxxxxxxxxx xxxxxxxxxxxxx podle §80 xxxx. 1 xxxx. x) xxxxxx x. 258/2000 Xx., x xxxxxxx xxxxxxxxx xxxxxx x x xxxxx některých xxxxxxxxxxxxx xxxxxx, ve xxxxx xxxxxxxxxx xxxxxxxx, stanoví xx xxxxxxx doporučení Xxxxxxx xxxxxxxxxx xxxxxx xxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx xxx xxxxxxxxxx, xxxxxxxx x xxxxxxxxx xxxxxxxx xxx xxx 2023:
1. Antigenní složení xxxxxxxxxx xxxxx pro xxxxxxxxxx xxxxxxxx
1x) xxxxxxxxxxx xxxxxxxx látka xxxxx xxxxxxx, xxxxxxxx kašli (xxxxxxxxxx forma), xxxxxx, xxxxxx přenosné obrně (xxxxxxxxxxxx xxxxx), virové xxxxxxxxxx B, xxxxxxx xxxxxxxxx Xxxxxxxxxxx xxxxxxxxxx xxx x (XXxXXxxXXXXXX)
Xx xxxxxxxxxxxx 1 xxxxx (0,5 ml) xxxxxxxx:
Xxxxxxxxxxx xxxxxxxxxx1 xx xxxx xxx 30 mezinárodních xxxxxxxx (XX)
Xxxxxx anatoxinum1 xx xxxx xxx 40 xxxxxxxxxxxxx jednotek (XX)
Xxxxxxxx Xxxxxxxxxx xxxxxxxxx:
Xxxxxxxxx xxxxxxxxxx (XX)1 25 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxxxxxxxxx xxxxxxxxxxxx (XXX)1 25 xxxxxxxxxx Xxxxxxxxxxx (PRN)1 8 xxxxxxxxxx
Xxxxxxxxx tegiminis xxxxxxxxxxx X (XXx)2,3 10 xxxxxxxxxx
Xxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx (XXX)
xxxxx 1 (xxxx Xxxxxxx)4 40 X xxxxxxxx antigenu
typus 2 (xxxx MEF-1)4 8 X xxxxxxxx xxxxxxxx
xxxxx 3 (xxxx Saukett)4 32 D xxxxxxxx xxxxxxxx
Xxxxxxxxxxx influenzae xxxxx x xxxxxxxxxxxxxxx
(Xxxxxxxxxxxxxxxxxxx phosphas) 10 xxxxxxxxxx
xxxx. cum xxxxxx. tetanico xxxx xxxxx xxxxxxx xxxxxxxxx 25 xxxxxxxxxx
1 xxxxxxxxxxx xx hydroxid xxxxxxx, xxxxxxxxxxx (Al(OH)3) 0,5 xxxxxxxxx Al3+
2 xxxxxxxx xxxxxxxxxxxxx DNA xxxxxxxxxxx xx xxxxxxx xxxxxxxxxxxx xxxxx Xxxxxxxxxxxxx xxxxxxxxxx)
3 xxxxxxxxxxx xx xxxxxxxxxxx xxxxxxx (AlPO4) 0,32 xxxxxxxxx Al3+
4 xxxxxxxxx xx XXXX xxxxxxx
XXXX
1xx) xxxxxxxxxxx xxxxxxxx xxxxx xxxxx xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx forma), xxxxxx, dětské přenosné xxxxx (inaktivovaná forma), xxxxxx xxxxxxxxxx X, xxxxxxx vyvolaným Xxxxxxxxxxx xxxxxxxxxx xxx b (XXxXXxxXXXXXX)
Xxxxx xxxxx1 (0,5 xx) xxxxxxxx:
Xxxxxxxxxxx anatoxinum xx xxxx xxx 20 xxxxxxxxxxxxx xxxxxxxx (XX)2
Xxxxxx anatoxinum ne xxxx xxx 40 xxxxxxxxxxxxx jednotek (IU)2
Antigeny Xxxxxxxxxx xxxxxxxxx
Xxxxxxxxx anatoxinum 25 xxxxxxxxxx
Xxxxxxxxxxxxxx filamentosum 25 xxxxxxxxxx
Xxxxx Xxxxxxxxxxxxxxx (xxxxxxxxxxxx)3
xxxxx 1 (Xxxxxxx) 40 D xxxxxxxx xxxxxxxx4
xxxxx 2 (XXX-1) 8 D jednotek xxxxxxxx4
xxxxx 3 (Saukett) 32 X xxxxxxxx xxxxxxxx4
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X5 10 mikrogramů
Polyribosylribitoli xxxxxxxx xxxxxxxxxx xxxxxxxxxx X 12 xxxxxxxxxx
(Xxxxxxxxxxxxxxxxxxx xxxxxxxx)
xxxxxxxxx xxx xxxxxx xxxxxxxxxx 22-36 mikrogramů
1 xxxxxxxxxxx na xxxxxxxxxxx xxxxxxxx xxxxxxx (0,6 xx Xx3+)
2 xxxx xxxxxx xxx xxxxxxxxxxxxx (x = 0,95)
3 xxxxxxxxx xx XXXX xxxxxxx
4 nebo xxxxxxxxxxxx xxxxxxxx xxxxxxxx xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx xxxxxxx
5 xxxxxxxx xxxxxxxxxxxxx DNA xxxxxxxxxxx v kvasinkových xxxxxxx Xxxxxxxxx xxxxxxxxxx
XXXX
1xx) Xxxxxxx xxxxx xxxxxxx, xxxxxx, xxxxxxxx kašli (xxxxxxxxxx xxxxxxxxxx), xxxxxxxxxx X (xXXX), xxxxxx xxxxxxxx xxxxx (inaktivovaná) x xxxxxxxxxxx xxxxxxx xxxxx Haemophilus xxxx x (xxxxxxxxxxx)
Xxxxx dávka (0,5 xx) xxxxxxxx:
Xxxxxxxxxxx xxxxxxxxxx1 xx méně xxx 20 IU
Tetani xxxxxxxxxx1 ne xxxx xxx 40 XX
Xxxxxxxx Xxxxxxxxxxx xxxxxxxx1
Xxxxxxxxx anatoxinum (XX) 20 xxxxxxxxxx
Xxxxxxxxxxxxxxx xxxxxxxxxxxx (XXX) 20 xxxxxxxxxx
Xxxxxxxxxxx (PRN) 3 xxxxxxxxxx
Xxxxxxxx typi 2 xx 3 (XXX) 5 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx B2,3 10 xxxxxxxxxx
Xxxxx xxxxxxxxxxxxxxx (xxxxxxxxxxx)4
Xxxxx 1 (Xxxxxxx) 40 X xxxxxxxx antigenu5
Typus 2 (XXX-1) 8 X jednotek xxxxxxxx5
Xxxxx 3 (Xxxxxxx) 32 X xxxxxxxx xxxxxxxx5
Xxxxxxxxxxxxxx Xxxxxxxxxx xxxxxxxxxx typus x
(Xxxxxxxxxxxxxxxxxxx xxxxxxxx) 3 xxxxxxxxxx xxxxxxxxxx xxx xxxxxxxxx xxxxxxxxxxxx xxxxx x2 50 xxxxxxxxxx
1 xxxxxxxxxxx na xxxxxxxxxxx xxxxxxx (0,17 xx Xx3+)
2 adsorbováno na xxxxxxxxxxx xxxxxxxx xxxxxxx xxxxxx (0,15 xx Xx3+)
3 vyrobeno rekombinantní XXX xxxxxxxxxxx v xxxxxxxxxxxx xxxxxxx Saccharomyces xxxxxxxxxx
4 xxxxxxxxx xx Xxxx buňkách
5 nebo xxxxxxxxxxxx množství antigenu xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx xxxxxxx.
1x) xxxxxxxx látka xxxxx xxxxxxx, dávivému xxxxx (acelulární xxxxx), xxxxxx (DTaP)
Jedna xxxxx (0,5 ml) obsahuje xxxx xxxxxx xxxxx:
Xxxxxxxxxxx xxxxxxxxxx* ≥ 30 XX
Xxxxxx xxxxxxxxxx* ≥ 40 IU
Pertussis anatoxinum* (XX) 25 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxxxxxxxx filamentosum* (XXX) 25 mikrogramů
Pertactinum* (69 xX) 8 mikrogramů
* xxxxxxxxxxx xx xxxxxxxx xxxxxxx xxxxxx: 0,5 xxxxxxxxx
XXXX
1xx) Xxxxxxxx xxxxx xxxxx záškrtu, xxxxxx x xxxxxxxx xxxxx (xxxxxxxxxx) se xxxxxxxx xxxxxxx antigenů (Xxxx)
Xxxxx xxxxx (0,5 xx) xxxxxxxx:
Xxxxxxxxxxx xxxxxxxxxx - Xxxxxxxxx 2 XX* (2 Xx)
Xxxxxx xxxxxxxxxx - Minimálně 20 XX* (5 Xx)
Xxxxxxxxx xxxxxxxx
Xxxxxxxxx xxxxxxxxxx - 2,5 xxxxxxxxxx
Xxxxxxxxxxxxxx xxxxxxxxxxxx - 5 xxxxxxxxxx
Xxxxxxxxxxx - 3 mikrogramy
Fimbriae, xxxx 2 xx 3 - 5 xxxxxxxxxx
Xxxxxxxxxxx na xxxxxxxxxxx xxxxxxx - 1,5 xx (0,33 mg xxxxxxx)
* Xxxx xxxxxx xxxxxxx intervalu spolehlivosti (x = 0,95) xxxxxxxx xxxxxx xxxxx xxxxx xxxxxxxxx x Xxxxxxxxx lékopisu.
NEBO
1bb) Xxxxxxxx xxxxx xxxxx xxxxxxx, xxxxxx x xxxxxxxx xxxxx (acelulární xxxxxxxxxx) xx xxxxxxxx xxxxxxx xxxxxxxx (Xxxx)
Xxxxx xxxxx (0,5 xx) obsahuje:
Diphtheriae xxxxxxxxxx1 ne xxxx xxx 2 mezinárodní xxxxxxxx (XX) (2,5 Xx)
Xxxxxx anatoxinum1 ne xxxx xxx 20 xxxxxxxxxxxxx xxxxxxxx (XX) (5 Lf)
Bordetellae xxxxxxxxx xxxxxxxx:
Xxxxxxxxx anatoxinum1 8 xxxxxxxxxx
Xxxxxxxxx haemagglutinum xxxxxxxxxxxx1 8 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxx xxxxxxxx xxxxxxxxx1 2,5 xxxxxxxxxx
1 xxxxxxxxxxx na xxxxxxxxxxx xxxxxxxx xxxxxxx (Xx(XX)3) 0,3 xxxxxxxxx Xx3+ x xxxxxxxxxxx xxxxxxx (XxXX4) 0,2 xxxxxxxxx Al3+
1c) xxxxxxxx xxxxx xxxxx xxxxxxx xxxxxxxxx Haemophilus xxxxxxxxxx xxx x:
Xxxxx dávka xxxxxxxxxxxxx xxxxxxx xxxxxxxx:
Xxxxxxxxxxxxxxx Xxx xxxxxxxxxxx (10 xxxxxxxxxx) xxx Xxxxxxxxx xxxxxxxx (přibližně 25 xxxxxxxxxx).
1x) xxxxxxxx xxxxx xxxxx xxxxxx:
Xxxxx xxxxx xxxxxxxx:
Xxxxxx xxxxxxxxxx - xxx. 40 xxxxxxxxxxxxx xxxxxxxx
1x) očkovací xxxxx xxxxx xxxxxx hepatitidě X x xxxxxx xxxxxxx:
Xxxxx xxxxx obsahuje:
Antigenum xxxxxxxxx xxxxxxxxxxx B - 10 mikrogramů
1f) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx X x dospělé xxxxxxx
Xxxxx xxxxx obsahuje:
Antigenum xxxxxxxxx xxxxxxxxxxx X - 20 xxxxxxxxxx
1x) xxxxxxxx xxxxx proti xxxxxxxxxx, xxxxxxxxxx x xxxxxxxxx:
Xxxxx xxxxx xxxxxxxx:
Xxxxxxxxxxx virus xxxxxxxxxx1 (Xxxxxxx) xxx. 103,0 infekční xxxxx xxx xxxxxxxx kulturu503
Parotitidis xxxxx xxxxxxxxxx1 (RIT 4385) min. 103,0 xxxxxxxx xxxxx xxx xxxxxxxx xxxxxxx503
Xxxxxxxx xxxxx xxxxxxxxxx2 (Xxxxxx RA 27/3) xxx. 103,0 xxxxxxxx xxxxx xxx xxxxxxxx xxxxxxx503
1 xxxxxxxxx xx buňkách xxxxxxxx xxxxxx
2 pomnoženo na xxxxxxxx diploidních xxxxxxx (XXX-5)
3 50% xxxxxxxx xxxxx xxxxxxx kultury
NEBO
1ga) xxxxxxxx xxxxx xxxxx xxxxxxxxxx, xxxxxxxxxx x xxxxxxxxx
Xx xxxxxxxxxx xxxxxxxx xxxxx xxxxx (0,5 xx):
Xxxxx xxxxxxxxxxx1 vivum xxxxxxxxxx (xxxx Enders’ Xxxxxxxxx) xx xxxx xxx 1x103 XXXX50*
Xxxxx xxxxxxxxxxx1 vivum xxxxxxxxxx (xxxx Jeryl Xxxx™, xxxxxxx B) xx xxxx než 12,5x103 XXXX50*
Xxxxx rubeolae2 vivum xxxxxxxxxx (xxxx Xxxxxx XX 27/3) xx xxxx xxx 1x103 XXXX50*
* 50 % xxxxxxxx dávka xxxxxxx xxxxxxx
1 xxxxxxxx na xxxxxxx kuřecích embryí.
2 xxxxxxxx xx xxxxxxxx xxxxxxxxxxx plicních XX-38 xxxxxxxxxxxxx.
1x) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxx xxxxx x inaktivované xxxxx:
Xxxxx xxxxx obsahuje:
Virus xxxxxxxxxxxxx xxxxxxxxxxx xxxxx 1 (Mahoney).....40 xxxxxxxxxxx X jednotek*
Virus xxxxxxxxxxxxx xxxxxxxxxxx xxxxx 2 (XXX-1) ..........8 xxxxxxxxxxx X xxxxxxxx*
Xxxxx poliomyelitis xxxxxxxxxxx xxxxx 3 (Xxxxxxx)........32 xxxxxxxxxxx X xxxxxxxx*
* nebo xxxxxxxx xxxxxxxxxxxxxx xxxxxxxx xxxxxxxxx xxxxxx vhodné xxxxxxxxxxxxx xxxxxx.
1xx) xxxxxxxx látky xxxxx xxxxxxxxxxxxx xxxxxxxx xxxxxxxxx x xxxxxxxxxx xxxxxxxx:
1xxx) konjugovaná xxxxxxxx xxxxx obsahuje:
Streptococci xxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 11 2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 31 2,2 µx
Xxxxxxxxxxxx pneumoniae xxxxxxxxxxxxxxx sérotypus 41 2,2 µg
Streptococci xxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 51 2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 6A1 2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 6X1 4,4 µx
Xxxxxxxxxxxx pneumoniae xxxxxxxxxxxxxxx xxxxxxxxx 7F1 2,2 µg
Streptococci pneumoniae xxxxxxxxxxxxxxx xxxxxxxxx 9V1 2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 141 2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 18C1 2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 19X1 2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 19F1 2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 23X1 2,2 µx
1 Xxxxxxxxxx x xxxxxx proteinem XXX197 x xxxxxxxxxx xx xxxxxxxxxxx xxxxxxx (0,125 mg xxxxxxx).
1xxx) xxxxxxxxxxxxxxx xxxxxxxx xxxxx xxxxxxxx:
xx 25 mikrogramech xxxxxxxxxxxxx 23 xxxxxxxxxxxxxx xxxxxxxxxxxxxxxxx xxxxxxxx: 1, 2, 3, 4, 5, 6B, 7X, 8, 9X, 9V, 10X, 11X, 12F, 14, 15X, 17F, 18X, 19X, 19X, 20, 22X, 23F, 33X.
1x) xxxxxxxx xxxxx xxxxx záškrtu, xxxxxxxx xxxxx (xxxxxxxxxx forma), xxxxxx, xxxxxx xxxxxxxx xxxxx (xxxxxxxxxxxx xxxxx):
Xxxxx xxxxx (0,5 xx) xxxxxxxx:
Xxxxxxxxxxx anatoxinum1 - xx xxxx xxx 2 xxxxxxxxxxx jednotky (XX) (2,5 Lf)
Tetani xxxxxxxxxx1 - ne xxxx xxx 20 xxxxxxxxxxxxx xxxxxxxx (IU) (5 Lf)
Bordetellae xxxxxxxxx xxxxxxxx:
Xxxxxxxxx xxxxxxxxxx1 - 8 mikrogramů
Pertussis xxxxxxxxxxxxxx xxxxxxxxxxxx1 - 8 xxxxxxxxxx
Xxxxxxxxx1 2,5 xxxxxxxxxx
Xxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx:
xxxxx 1 (xxxx Xxxxxxx)2 - 40 X xxxxxxxx xxxxxxxx
xxxxx 2 (kmen XXX-1)2 - 8 X xxxxxxxx antigenu
typus 3 (xxxx Xxxxxxx)2 - 32 X xxxxxxxx antigenu
1 Adsorbováno xx xxxxxxxxxxx hydroxid xxxxxxx (Al(OH)3) 0,3 xxxxxxxxx Al3+ a xxxxxxxxxxx xxxxxxx (XxXX4) 0,2 xxxxxxxxx Al3+
2 xxxxxxxxx na VERO xxxxxxx
XXXX
1xx) očkovací xxxxx xxxxx xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx forma), xxxxxx, xxxxxx přenosné xxxxx (xxxxxxxxxxxx xxxxx):
Xxxxx xxxxx (0,5 xx) xxxxxxxx:
Xxxxxxxxxxx anatoxinum xxxxxxxxx 2 IU* (2,5 Xx)
Xxxxxx xxxxxxxxxx minimálně 20 XX* (5 Xx)
Xxxxxxxxx xxxxxxxx:
Xxxxxxxxx xxxxxxxxxx 2,5 mikrogramů
Pertussis haemagglutininum xxxxxxxxxxxx 5 xxxxxxxxxx
Xxxxxxxxxxx 3 mikrogramy
Fimbriae, typi 2 xx 3 5 mikrogramů
Virus xxxxxxxxxxxxxxx (xxxxxxxxxxx)**
xxxxx 1 40 X xxxxxxxx antigenu
typus 2 8 X xxxxxxxx xxxxxxxx
xxxxx 3 32 X xxxxxxxx xxxxxxxx
Xxxxxxxxxxx xx fosforečnan xxxxxxx 1,5 xx (0,33 mg xxxxxxx)
* Xxxx spodní hranice xxxxxxxxx xxxxxxxxxxxxx (x = 0,95) xxxxxxxx xxxxxx podle testu xxxxxxxxx v Xxxxxxxxx xxxxxxxx.
** Kultivováno xx Xxxx xxxxxxx.
1x) xxxxxxxx xxxxx xxxxx tuberkulóze (XXX xxxxxxx)
1x) očkovací xxxxx xxxxx xxxxxx xxxxxxxxxx X xxx xxxxx xxxxxxxx xx xxxxxxxxxxxx xxxxxxxx:
Xxxxx dávka (0,5 xx) vakcíny xxxxxxxx:
Xxxxxxxxx xxxxxxxxx hepatitidis X1,2,3 - 20 xxxxxxxxxx
1 xxxxxxxxxx xx XX04X xxxxxxxxxx: - 3-0-xxxxxx-4'-xxxxxxxxxxxx-xxxxx A (XXX)2 50 mikrogramů
2 adsorbovaný xx fosforečnan hlinitý (xxxxxx 0,5 xxxxxxxxx Xx3+)
3 xxxxxxxx na xxxxxxx xxxxxxxxxxxx xxxxx (Xxxxxxxxxxxxx xxxxxxxxxx) xxxxxxxxxxxxx XXX xxxxxxxxxxx.
2. Xxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx xxx zvláštní očkování
2a) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx X xx xxxxxxx xxx xxxxxxx:
Xxxxx xxxxx xxxxxxxx:
Xxxxxxxxx xxxxxxxxx hepatitidis X - 20 xxxxxxxxxx
2x) xxxxxxxx xxxxx xxxxx xxxxxxxxx
2x) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx X ve xxxxxxx xxx dospělé:
Jedna xxxxx xxxxxxxx:
Xxxxxxxxx X xxxxx xxxxxxxxxxx
2x) xxxxxxxx xxxxx xxxxx xxxxxxxxxx, příušnicím x xxxxxxxxx:
Xxxxx dávka xxxxxxxx:
Xxxxxxxxxxx xxxxx xxxxxxxxxx1 (Xxxxxxx) min. 103,0 xxxxxxxx xxxxx pro xxxxxxxx xxxxxxx503
Xxxxxxxxxxx xxxxx xxxxxxxxxx1 (XXX 4385) xxx. 103,7 infekční xxxxx xxx xxxxxxxx xxxxxxx503
Xxxxxxxx xxxxx xxxxxxxxxx2 (Xxxxxx XX 27/3) xxx. 103,0 infekční xxxxx xxx xxxxxxxx xxxxxxx503
1 pomnoženo xx xxxxxxx xxxxxxxx xxxxxx
2 xxxxxxxxx xx lidských xxxxxxxxxxx buňkách (XXX-5)
3 50% infekční xxxxx xxxxxxx xxxxxxx
XXXX
2xx) xxxxxxxx xxxxx xxxxx xxxxxxxxxx, xxxxxxxxxx x xxxxxxxxx
Xx xxxxxxxxxx obsahuje xxxxx xxxxx (0,5 xx):
Xxxxx xxxxxxxxxxx1 xxxxx xxxxxxxxxx (xxxx Enders’ Edmonston) xx xxxx než 1x103 XXXX50*
Xxxxx parotitidis1 xxxxx xxxxxxxxxx (kmen Xxxxx Xxxx™, xxxxxxx X) xx méně xxx 12,5x103 CCID50*
Virus xxxxxxxx2 xxxxx attenuatum (xxxx Xxxxxx XX 27/3) xx xxxx xxx 1x103 XXXX50*
* 50 % xxxxxxxx xxxxx xxxxxxx kultury
1 xxxxxxxx xx buňkách xxxxxxxx embryí.
2 xxxxxxxx xx lidských diploidních xxxxxxxx XX-38 fibroblastech.
3. Xxxxxxxxx xxxxxxx očkovacích xxxxx xxx xxxxxxxxx xxxxxxxx
3x) očkovací xxxxx xxxxx xxxxxx xxxxxxxxxx X xx xxxxxxx xxx dospělé:
Virus hepatitis X xxxxxxxxxxx
3x) očkovací xxxxx proti virové xxxxxxxxxx X ve xxxxxxx pro xxxx:
Xxxxx xxxxxxxxx X xxxxxxxxxxx
3x) xxxxxxxx xxxxx xxxxx xxxxxxxxxx, xxxxxxxxxx x xxxxxxxxx:
Xxxxx xxxxx xxxxxxxx:
Xxxxxxxxxxx xxxxx attenuatum1 (Schwarz) xxx. 103,0 xxxxxxxx xxxxx pro buněčnou xxxxxxx503
Xxxxxxxxxxx virus xxxxxxxxxx1 (XXX 4385) min. 103,7 xxxxxxxx xxxxx xxx xxxxxxxx xxxxxxx503
Xxxxxxxx xxxxx attenuatum2 (Xxxxxx XX 27/3) min. 103,0 xxxxxxxx xxxxx xxx buněčnou xxxxxxx503
1 xxxxxxxxx na xxxxxxx xxxxxxxx xxxxxx
2 xxxxxxxxx xx xxxxxxxx xxxxxxxxxxx xxxxxxx (MRC-5)
3 50% xxxxxxxx xxxxx tkáňové xxxxxxx
XXXX
3xx) xxxxxxxx xxxxx xxxxx xxxxxxxxxx, xxxxxxxxxx x xxxxxxxxx
Xx xxxxxxxxxx xxxxxxxx jedna xxxxx (0,5 xx):
Xxxxx morbillorum1 xxxxx attenuatum (kmen Xxxxxx’ Edmonston) xx xxxx než 1x103 XXXX50*
Xxxxx xxxxxxxxxxx1 vivum xxxxxxxxxx (xxxx Xxxxx Xxxx™, xxxxxxx B) xx xxxx xxx 12,5x103 XXXX503
Xxxxx xxxxxxxx2 xxxxx xxxxxxxxxx (xxxx Xxxxxx XX 27/3) xx xxxx xxx 1x1103 CCID503
* 50% xxxxxxxx xxxxx xxxxxxx xxxxxxx
1 xxxxxxxx xx xxxxxxx xxxxxxxx embryí.
2 xxxxxxxx na xxxxxxxx xxxxxxxxxxx plicních XX-38 xxxxxxxxxxxxx.
&xxxx;
Xxxxxxx:
xxxx. XXXx. Válek, XXx., MBA, EBIR, x. r.
Xxxxxxxxx
Xxxxxx xxxxxxx č. 41/2023 Xx. xxxxx xxxxxxxxx xxxx 22.2.2023.
Xx xxx xxxxxxxx xxxxxx xxxxxxx nebyl xxxxx xx doplňován.
Znění xxxxxxxxxxxx xxxxxxxx xxxxx xxxxxx xxxxxxxx xxxxxxxx x xxxxxxxx xxxx xxxxxxxxxxxxx, xxxxx xx xxxx xxxxxx xxxxxxxxx změna xxxxx xxxxxxxxx právního xxxxxxxx.